In the present study, the distribution of different subtypes of macrophages was evalutated in 485 clinical specimens of CRC, using nitric oxide synthase 2 (NOS2) as a marker for the M1 macrophage phenotype and the scavenger receptor CD163 as a marker for the M2 macrophage phenotype. Here, CD163 is linked to colorectal carcinoma.